Monitoring drug therapy in the intensive care unit

Area of Science:

• Pharmacology
• Critical Care Medicine
• Patient Safety

Background:

• Patients in intensive care units (ICUs) receive a high volume of therapeutic interventions.
• Monitoring drug efficacy and toxicity is a complex challenge for ICU practitioners.
• Standard monitoring may not fully address the nuances of drug therapy in critical illness.

Purpose of the Study:

• To present a conceptual framework for monitoring drug efficacy in the ICU.
• To guide practitioners in identifying predictable and unpredictable adverse drug effects.
• To clarify the role of therapeutic drug monitoring (TDM) within a comprehensive monitoring strategy.

Main Methods:

• Conceptual review of drug monitoring principles in critical care.
• Discussion of strategies for assessing therapeutic response.
• Integration of adverse drug event detection methods.
• Highlighting the specific utility of TDM for certain medications.

Main Results:

• A structured approach to drug therapy monitoring in ICUs is proposed.
• Framework addresses both efficacy and toxicity, encompassing predictable and unpredictable events.
• Therapeutic drug monitoring (TDM) is identified as crucial for a subset of drugs.
• Emphasis on proactive and systematic patient management.

Conclusions:

• Effective drug therapy monitoring in the ICU requires a multifaceted conceptual approach.
• Systematic assessment enhances patient safety by optimizing drug efficacy and minimizing toxicity.
• Therapeutic drug monitoring (TDM) remains an important, albeit selective, tool in critical care pharmacotherapy.